Effect of angiotensin-converting enzyme inhibition on Na+/H+-exchange and Ca2+-efflux in human erythrocytes

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 19, Issue 2, 1997, Pages 125-128

  Lijnen, P ^a,c   Arabidze, C G ^b   Petrov, V ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

ACE inhibition; Ca2+ efflux; captopril; Na+ H+ exchange

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CALCIUM METABOLISM; CALCIUM TRANSPORT; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; ENZYME INHIBITION; ERYTHROCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM; CAPTOPRIL; CELL MEMBRANE; ERYTHROCYTES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SODIUM-HYDROGEN ANTIPORTER;

EID: 0030940776     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Lindpaintner, K., Jim, M., Wilhem, M.J. Intracardiac generation of angiotensin and its physiologic role. Circulation 1988, 77 (Suppl. I): 1-18.
2. Linz, W., Scholkens, B.A., Lindpaintner, K., Ganten, D. Cardiac renin-angiotensin system. Am J Hypertens 1989, 2: 307-10.
3. Schunkert, H., Dzau, V.J., Tang, S.S., Hirsch, A.T., Apstein, C.S., Lorell, B.H. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. J Clin Invest 1990, 36: 1913-20.
4. Kramer, HJ., Glänzer, K., Meyer-Lehnert, H., Mohaupt, M., Predel, M.G. Kinin- and nonkinin-mediated interactions of converting enzyme inhibitors with vasoactive hormones. J Cardiovasc Pharmacol 1990, 15 (Suppl. 6): S91-8.
5. Linz., W., Wiemer, G., Scholkens, B.A. Contribution of bradykinin to the cardiovascular effects of ramipril. J Cardiovasc Pharmacol 1993, 22 (Suppl. 9): S1-8.
6. Unger, T., Gohlke, P. Tissue renin-angiotensin systems in the heart and vasculature: Possible involvement in the cardiovascular actions of converting enzyme inhibitors. Am J Cardiol 1990, 65: 31-40.
7. Staessen, J., Fagard, R., Lijnen, P., Verschueren, L.J., Amery, A. Fluctuations of the plasma angiotensin I converting enzyme activity during long-term treatment with captopril. Acta Cardiol 1982, 37: 1-9.
8. Cohen, M.L., Kurz, K.D. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421. J Pharmacol Exp Ther 1982, 220: 63-9.
9. Velletri, P., Bean, B.L. The effect of captopril on rat aortic angiotensin-converting enzyme. J Cardiovasc Pharmacol 1982, 4: 315-25.
10. Unger, T., Ganten, D., Lange, R.E., Scholkens, B.A. Persistent tissue converting enzyme inhibition following chronic hypertensive rats. J Cardiovasc Pharmacol 1985, 7: 36-41.
11. Dzau, V.J. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 1988, 7 (Suppl. 1): 14-13.
12. Kikta, D.C., Fregly, M.J. Effect of in vitro administration of captopril on vascular reactivity of rat aorta. Hypertension 1982, 4: 118-24.
13. Antonaccio, M.J., Kerwin, L. Pre- and postjunctional inhibition of vascular sympathetic function by captopril in SHR: Implication of vascular angiotensin II in hypertension and antihypertensive actions of captopril. Hypertension 1981, 3 (Suppl. 1): 1654-62.
14. +ATPase. Clin Physiol Biochem 1989, 7: 101-18.
15. Sada, T., Keike, H., Ikeda, M., Ozaki, H., Karaki, H. Cytosolic-free calcium in hypertensive rats. Hypertension 1990, 16: 245-51.
16. +-exchange by soluble and particulate guanylate cyclase. Am J Physiol 1996, 271 : C1556-64..
17. Postnov, Y.V., Orlov, S.N., Shevchenko, A., Adler, A.M. Altered sodium permeability, calcium binding, and Na/K-ATPase activity in red blood cell membrane in essential hypertension. Pflügers Arch 1977, 371: 263-9.
18. 2+ transport in the erythrocytes of patients with essential hypertension. Clin Sci 1984, 66: 459-63.
19. Gill, J., Jeremy, J., Dandona, P. Captopril inhibits the influx of calcium into platelets. Eur J Pharmacol 1989,162: 193-4.
20. 2+-fluxes in aortic smooth muscle. Hypertension 1993, 22: 806-11.
21. Niutta, E., Cusi, D., Colombo, R. et al. Antihypertensive effect of captopril, canrenoate potassium and atenolol. Relations with red blood cell sodium transport and renin. Am J Hypertens 1988, 1: 64-371.
22. Santucci, A., Aguglia, F., Violi, F., De Mattia, G. Changes of the intralymphocytic sodium concentration after acute and chronic captopril administration. Am J Cardiol 1982, 49: 1513-4.
23. Ambrosioni, E., Costa, F.V., Borghi, C., Mussi, A. Influence of captopril on intracellular ions - A possible mode of action. Postgrad Med J 1986, 62 (Suppl. 1): 16-22.
24. - cotransport activity by enalapril. Hypertension 1991, 17: 334-9.
25. + pump in black and Caucasian hypertensive patients. Hypertension 1984, 6: 536-44.
26. + exchanger activity in normotensive and hypertensive subjects effect of enalapril upon antiport activity. J Hypertens 1992, 10: 839-47.